ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Georgia » Interventional Cardiology

Top Interventional Cardiology Prescribers in Georgia

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
MEHUL BHATT MD

Interventional Cardiology

2,034

$277K

280
225 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 27%

$136
Average prescription price

Avg: $61

CHARLES WILMER MD

Interventional Cardiology

5,056

$657K

447
410 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 27%

$130
Average prescription price

Avg: $61

CHARLES BROWN MD

Interventional Cardiology

2,961

$340K

383
345 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

40%
prescriptions for brand name drugs

Avg: 27%

$115
Average prescription price

Avg: $61

AHMED SHAH MD

Interventional Cardiology

770

$86.8K

84
50 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 27%

$113
Average prescription price

Avg: $61

NICHOLAS LEMBO MD

Interventional Cardiology

1,686

$157K

210
182 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 27%

$93
Average prescription price

Avg: $61

ROBERT HOFF MD

Interventional Cardiology

5,324

$487K

461
428 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 27%

$91
Average prescription price

Avg: $61

VIVEK RAJAGOPAL MD

Interventional Cardiology

783

$70.1K

100
85 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 27%

$90
Average prescription price

Avg: $61

WILLIAM KNOPF MD

Interventional Cardiology

1,639

$144K

146
133 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 27%

$88
Average prescription price

Avg: $61

WILLIAM BALLARD MD

Interventional Cardiology

1,601

$134K

239
209 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 27%

$84
Average prescription price

Avg: $61

KHUSROW NIAZI MD

Interventional Cardiology

1,116

$89.9K

171
149 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 27%

$81
Average prescription price

Avg: $61

WILLIAM BLINCOE MD

Interventional Cardiology

2,040

$162K

252
230 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 27%

$80
Average prescription price

Avg: $61

AMOL BAPAT M.D.

Interventional Cardiology

3,970

$312K

311
294 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 27%

$79
Average prescription price

Avg: $61

VIKRAM MANDADI MD

Interventional Cardiology

3,061

$231K

315
249 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 27%

$76
Average prescription price

Avg: $61

VICTOR CORRIGAN MD

Interventional Cardiology

2,622

$187K

284
259 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 27%

$71
Average prescription price

Avg: $61

ARTHUR REITMAN M.D.

Interventional Cardiology

4,391

$308K

343
310 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 27%

$70
Average prescription price

Avg: $61

DIMITRIOS KARMPALIOTIS MD

Interventional Cardiology

886

$61.2K

104
81 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 27%

$69
Average prescription price

Avg: $61

KULDEEP TALWAR MD

Interventional Cardiology

743

$51.3K

154
131 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 27%

$69
Average prescription price

Avg: $61

BHAGAT REDDY MD

Interventional Cardiology

986

$67.9K

166
144 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 27%

$69
Average prescription price

Avg: $61

HAROLD CARLSON MD

Interventional Cardiology

2,787

$190K

303
254 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 27%

$68
Average prescription price

Avg: $61

CHRISTOPHER LEGGETT M.D.

Interventional Cardiology

610

$40.7K

90
69 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 27%

$67
Average prescription price

Avg: $61

WILLIAM KNAPP MD

Interventional Cardiology

7,033

$454K

616
547 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 27%

$65
Average prescription price

Avg: $61

HOWARD SNAPPER M.D.

Interventional Cardiology

4,432

$277K

370
319 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 27%

$62
Average prescription price

Avg: $61

BARRY MANGEL M.D.

Interventional Cardiology

4,274

$267K

351
310 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 27%

$62
Average prescription price

Avg: $61

SALVATORE MANNINO D.O.

Interventional Cardiology

4,384

$273K

333
282 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

25%
prescriptions for brand name drugs

Avg: 27%

$62
Average prescription price

Avg: $61

SANDEEP CHANDRA MD FACC

Interventional Cardiology

12,163

$751K

670
518 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 27%

$62
Average prescription price

Avg: $61

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank